坏死年轻恒牙再生性牙髓治疗随机临床试验的CONSORT依从性:范围综述
该范围综述纳入20项坏死年轻恒牙再生性牙髓治疗的临床试验,评估其方法学质量与CONSORT声明依从性。平均CONSORT依从性得分为20.95(±6.19),仅3项研究为低偏倚风险,9项为高偏倚风险。报告充分性低,偏倚风险中至高,且高收入国家研究得分更高。
要点
- 再生性牙髓治疗临床试验的CONSORT报告依从性普遍较低。
- 仅3/20项研究为低偏倚风险,9项为高偏倚风险。
- 高收入国家的研究CONSORT得分更高,报告质量与偏倚风险相关。
核心结论
- 再生性牙髓治疗临床试验基于CONSORT清单的报告充分性低,偏倚风险为中至高度。
研究设计与样本
- 范围综述,电子检索8个数据库,纳入20项对坏死恒牙未成熟牙行再生性牙髓治疗的临床试验。
- 使用Cochrane偏倚风险评估工具(RoB 2.0)评估质量,并用0-2分工具评估CONSORT依从性(总分32分)。
主要发现
- 平均CONSORT依从性得分为20.95(±6.19)。
- 报告最好的条目是干预措施描述(100%),其次为分析患者数、失访和排除(90%)及检验假设(85%)。
- 3项研究为低偏倚风险,8项为一些担忧,9项为高偏倚风险。
- CONSORT得分与低偏倚风险领域百分比呈中度相关(rs=0.63;95%CI 0.31-0.94;P=.003),与总体偏倚风险类别呈中度相关(rs=0.76;95%CI 0.54-0.98;P=.001)。
关键数值与推荐
- CONSORT依从性评分工具:0=无描述,1=不足,2=充分描述,总分最高32分。
- 高收入水平国家的研究CONSORT得分更高。
临床怎么用
- 开展再生性牙髓治疗临床试验时应遵循CONSORT声明以提高报告质量。
- 解读相关试验结果时需考虑其中至高度偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aimed to investigate methodological quality of clinical trials in regenerative endodontics and its compliance with the CONSORT statement. METHODS: An electronic search was performed in 8 electronic databases. Only clinical trials whose participants underwent regenerative endodontic treatment on necrotic permanent immature teeth were included. Quality assessment was performed using the Cochrane Collaboration's Risk of Bias Tool (RoB, version 2.0). Compliance of articles with the CONSORT guidelines was assessed by a tool with scales: 0 = no description, 1 = deficient, and 2 = adequate description, totaling a maximum score of 32 points. The Mann-Whitney and Kruskal-Wallis tests were used to compare the scores among journals, studies, country, income levels, and publication periods. Spearman correlation analyses were performed between CONSORT compliance scores and 2019 journal CiteScore values, publication year, and quality assessment. RESULTS: Twenty studies were included. The average CONSORT compliance score was 20.95 (±6.19). The better reported items were the description of the interventions performed in the trials (100%), followed by the description of the number of patients analyzed, losses and exclusions (90%), and the hypothesis tested (85%). Within the 20 studies, 3 articles were classified as "low risk of bias," 8 studies were classified as "some concerns," and 9 studies were considered "high risk of bias." Studies carried out in countries with higher income levels presented higher CONSORT scores. Significant moderate correlations were found between the CONSORT score and the percentage of risk of bias in low-risk domains (rs = 0.63; 95% CI, 0.31-0.94; P = .003) and the overall risk of bias categories (rs = 0.76; 95% CI, 0.54-0.98; P = .001). CONCLUSIONS: The adequacy of reporting based on the CONSORT checklist items of regenerative endodontic trials was low with a moderate to high risk of bias.
引用
- Sponchiado-Júnior EC, Vieira WA, Frozoni M, et al. CONSORT Compliance in Randomized Clinical Trials of Regenerative Endodontic Treatments of Necrotic Immature Teeth: A Scoping Review. J Endod. 2021. PMID: 34352304. doi:10.1016/j.joen.2021.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。